BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 601066)

  • 1. Immune response to myelin basic protein in multiple sclerosis.
    Hughes RA; Gray I; Clifford-Jones R; Stern M
    Proc R Soc Med; 1977 Dec; 70(12):874-6. PubMed ID: 601066
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple sclerosis. Presenting an odd autoantigen.
    Steinman L
    Nature; 1995 Jun; 375(6534):739-40. PubMed ID: 7541112
    [No Abstract]   [Full Text] [Related]  

  • 3. Antimyelin basic protein antibodies and cellular hypersensitivity in multiple sclerosis.
    Sheremata W; Wood DD; Moscarello MA
    Trans Am Neurol Assoc; 1976; 101():291-4. PubMed ID: 1028264
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antibodies against encephalitogenic protein and myelin glycoprotein in the cerebrospinal fluid of patients with multiple sclerosis. Effect of encorton treatment on the autoantibody and immune complex levels].
    Waigt A; Górny MK
    Folia Med Cracov; 1984; 25(3-4):307-18. PubMed ID: 6085729
    [No Abstract]   [Full Text] [Related]  

  • 5. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis.
    Ota K; Matsui M; Milford EL; Mackin GA; Weiner HL; Hafler DA
    Nature; 1990 Jul; 346(6280):183-7. PubMed ID: 1694970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct leukocyte migration inhibition by myelin basic protein in exacerbations of multiple sclerosis.
    Sheremata W; Triller H; Cosgrove JB; Eylar EH
    Can Med Assoc J; 1977 May; 116(9):985-8. PubMed ID: 870161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiopathology of multiple sclerosis.
    Visconti A; Santucci S; Figà Talamanca L; Cannoni S; Ristori G; Salvetti M
    Neurol Sci; 2003 Dec; 24 Suppl 5():S287-90. PubMed ID: 14652791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelin basic protein and proteolipid protein reactivity of brain- and cerebrospinal fluid-derived T cell clones in multiple sclerosis and postinfectious encephalomyelitis.
    Hafler DA; Benjamin DS; Burks J; Weiner HL
    J Immunol; 1987 Jul; 139(1):68-72. PubMed ID: 2438352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathogenesis of multiple sclerosis. Antibody dependent cytotoxicity of lymphocytes against myelin basic proteins in multiple sclerosis].
    Frick E; Stickl H
    Fortschr Med; 1977 Oct; 95(37):2235-41. PubMed ID: 914178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimyelin basic protein and antimyelin antibody-producing cells in multiple sclerosis.
    Olsson T; Baig S; Höjeberg B; Link H
    Ann Neurol; 1990 Feb; 27(2):132-6. PubMed ID: 1690527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Auto-immunity and multiple sclerosis].
    Goudemand M
    Lille Med; 1973 Nov; 18(9):1149-57. PubMed ID: 4603354
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunological studies in multiple sclerosis].
    Rysková O; Pekárek J; Vejbora O; Chromová L
    Cesk Neurol Neurochir; 1981 Mar; 44(2):108-15. PubMed ID: 6165493
    [No Abstract]   [Full Text] [Related]  

  • 13. [Multiple sclerosis. Risk factors].
    Drăgănescu N
    Virologie; 1987; 38(3):223-34. PubMed ID: 3310380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current therapy of multiple sclerosis. Oral tolerance induction to myelin antigens].
    Voltz R; Hohlfeld R
    Nervenarzt; 1993 Jun; 64(6):411-2. PubMed ID: 8332235
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of I-125 labeled encephalitogenic protein on the surface of blood lymphocytes].
    Diessner H; Neumann V; Schmidt RM
    Schweiz Arch Neurol Neurochir Psychiatr; 1974; 114(1):57-66. PubMed ID: 4133176
    [No Abstract]   [Full Text] [Related]  

  • 16. [Lymphocyte sensitivity to phytohemagglutin (PHA) and pokeweed mitogen (PWM) in patients with multiple sclerosis].
    Czernicki J; Chmielewski H; Jurkowski A
    Pol Tyg Lek; 1974 May; 29(21):881-3. PubMed ID: 4840200
    [No Abstract]   [Full Text] [Related]  

  • 17. Activation of myelin reactive T cells in multiple sclerosis: a possible role for T cell degeneracy?
    Stinissen P; Hellings N
    Eur J Immunol; 2008 May; 38(5):1190-3. PubMed ID: 18425726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen cross-reactivity in the macrophage electrophoretic mobility test. A study using cellular affinity chromatography.
    McDermott JR; Caspary EA; Dickinson JP
    Clin Exp Immunol; 1974 May; 17(1):103-11. PubMed ID: 4143111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Perspectives in multiple sclerosis research].
    Lassmann H
    Wien Med Wochenschr; 1996; 146(19-20):528-32. PubMed ID: 9082653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular hypersensitivity in attacks of multiple sclerosis. I. A comparative study of migration inhibitory factor production and lymphoblastic transformation in response to myelin basic protein in multiple sclerosis.
    Colby SP; Sheremata W; Bain B; Eylar EH
    Neurology; 1977 Feb; 27(2):132-9. PubMed ID: 556829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.